Structures by: Huuskonen J.
Total: 31
C20H28BrCuN4OS2
C20H28BrCuN4OS2
Acta Chemica Scandinavica (1997) 51, 462-469
a=9.799(3)Å b=10.416(1)Å c=12.947(1)Å
α=66.186(9)° β=73.45(2)° γ=85.07(2)°
C22H30N4S2
C22H30N4S2
Acta Chemica Scandinavica (1997) 51, 462-469
a=9.1239(8)Å b=9.518(2)Å c=7.3299(7)Å
α=95.26(9)° β=107.805(7)° γ=112.17(1)°
C20H26N4S2
C20H26N4S2
Acta Chemica Scandinavica (1997) 51, 462-469
a=8.459(1)Å b=10.552(2)Å c=22.823(3)Å
α=90.° β=90.° γ=90.°
C19H33N5O2
C19H33N5O2
Acta Chemica Scandinavica (1999) 53, 194-201
a=9.998(2)Å b=15.476(3)Å c=12.957(3)Å
α=90.° β=92.64(2)° γ=90.°
C32H40.5BF4N0.5O8
C32H40.5BF4N0.5O8
Acta Chemica Scandinavica (1998) 52, 563-570
a=14.158(2)Å b=14.791(2)Å c=16.384(2)Å
α=90° β=93.90(1)° γ=90°
C32H38.5BF4N2.5O6
C32H38.5BF4N2.5O6
Acta Chemica Scandinavica (1998) 52, 563-570
a=26.113(3)Å b=13.933(1)Å c=19.004(2)Å
α=90° β=125.05(2)° γ=90°
C27H31BF4O6
C27H31BF4O6
Acta Chemica Scandinavica (1998) 52, 563-570
a=13.1260(2)Å b=13.1260(2)Å c=15.1338(2)Å
α=90° β=90° γ=90°
Compound X
C68H80N4O4,C10H16N2O2,4(CHCl3)
Organic & biomolecular chemistry (2012) 10, 30 5954-5964
a=13.087(3)Å b=13.192(2)Å c=14.620(3)Å
α=103.23(2)° β=107.21(3)° γ=108.81(2)°
Compound X
C68H80N4O4,C18H20N2O2,2(CHCl3)
Organic & biomolecular chemistry (2012) 10, 30 5954-5964
a=25.976(5)Å b=19.610(4)Å c=19.930(4)Å
α=90° β=126.21(3)° γ=90°
C50H66N2O12
C50H66N2O12
New Journal of Chemistry (1999) 23, 12 1245-1252
a=12.466(2)Å b=11.9827(18)Å c=16.456(2)Å
α=90° β=105.918(12)° γ=90°
C54.5H70.5Cl1.5N2O17
C54.5H70.5Cl1.5N2O17
New Journal of Chemistry (1999) 23, 12 1245-1252
a=14.0149(12)Å b=12.7542(12)Å c=17.837(2)Å
α=90° β=108.711(8)° γ=90°
C54H78F12N4O16P2
C54H78F12N4O16P2
New Journal of Chemistry (1999) 23, 12 1245-1252
a=12.263(2)Å b=22.3356(13)Å c=22.566(2)Å
α=90° β=94.169(11)° γ=90°
C48H48FeN6O12,C6H14O,C2H3N,2(ClO4)
C48H48FeN6O12,C6H14O,C2H3N,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 21 5706-5710
a=14.9147(2)Å b=24.5620(4)Å c=16.5450(2)Å
α=90° β=94.7070(10)° γ=90°
C78H84FeN15O9,4(ClO4),C2F3O2,H2O,C
C78H84FeN15O9,4(ClO4),C2F3O2,H2O,C
Dalton transactions (Cambridge, England : 2003) (2011) 40, 21 5706-5710
a=13.6922(14)Å b=18.3992(14)Å c=19.312(2)Å
α=110.059(4)° β=91.044(6)° γ=94.961(6)°
C72H71FeN15O9,2(O4S),O26
C72H71FeN15O9,2(O4S),O26
Dalton transactions (Cambridge, England : 2003) (2011) 40, 21 5706-5710
a=13.8873(2)Å b=24.0212(3)Å c=31.2772(4)Å
α=90° β=101.1260(10)° γ=90°
C21H24N10O
C21H24N10O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 45 13848-13855
a=9.0437(7)Å b=15.1679(10)Å c=16.2868(13)Å
α=90.00° β=92.566(4)° γ=90.00°
C22H24N10,H2O
C22H24N10,H2O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 45 13848-13855
a=11.0604(3)Å b=20.2397(11)Å c=10.3186(5)Å
α=90.00° β=101.884(3)° γ=90.00°
C20H20N10,C2H6O
C20H20N10,C2H6O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 45 13848-13855
a=7.8886(3)Å b=11.4824(7)Å c=25.5965(16)Å
α=92.693(2)° β=92.650(3)° γ=94.577(4)°
2(C80H80N40Zn4),16(ClO4),5(C2H3N),8(H2O)
2(C80H80N40Zn4),16(ClO4),5(C2H3N),8(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 45 13848-13855
a=24.517(5)Å b=19.460(4)Å c=24.071(5)Å
α=90.00° β=91.50(3)° γ=90.00°
Compound X
C80H80Co4N40,7(F6P),Cl,8(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 45 13848-13855
a=19.069(4)Å b=19.069Å c=24.440(5)Å
α=90.00° β=90.00° γ=90.00°
C80H80N40Co4,8(CF3SO3),6(C2H3N),6(H2O)
C80H80N40Co4,8(CF3SO3),6(C2H3N),6(H2O)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 45 13848-13855
a=17.0408(4)Å b=29.0227(6)Å c=31.0259(5)Å
α=95.280(1)° β=98.156(1)° γ=97.466(1)°
C104H98B8F32Fe4N52O3.5
C104H98B8F32Fe4N52O3.5
Dalton transactions (Cambridge, England : 2003) (2012) 41, 45 13848-13855
a=18.5204(3)Å b=27.2996(5)Å c=29.4421(4)Å
α=90.00° β=90.00° γ=90.00°
2(C36H48N6),C6F4I2,CHCL3
2(C36H48N6),C6F4I2,CHCL3
Chemical communications (Cambridge, England) (2009) 34, 16 2160-2162
a=24.6450(7)Å b=5.8927(2)Å c=27.7544(6)Å
α=90° β=99.404(2)° γ=90°
2(C37H42N6),2(C6F4I2),CHCl3
2(C37H42N6),2(C6F4I2),CHCl3
Chemical communications (Cambridge, England) (2009) 34, 16 2160-2162
a=5.9855(2)Å b=33.6650(10)Å c=22.8345(8)Å
α=90° β=95.906(2)° γ=90°
Iodoproxyfan
C13H16IN2O1,C4H3O41
Acta Crystallographica Section C (1999) 55, 4 IUC9900035
a=5.493(2)Å b=10.104(2)Å c=16.288(4)Å
α=97.26(2)° β=93.40(2)° γ=92.60(3)°
Dioxobis(pentane-2,4-dionato)(dimethylformamide)uranium(VI)
C13H21N1O7U1
Acta Crystallographica Section E (2007) 63, 2 m413-m414
a=8.56000(10)Å b=12.8018(3)Å c=15.5510(4)Å
α=90° β=90° γ=90°
2(S)-amino-3-(1H-imidazol-4(5)-yl)propyl cyclohexylmethyl ether dihydrochloride
C13H25N3O2,2Cl1
Acta Crystallographica Section C (2000) 56, 5 e216-e217
a=7.8270(4)Å b=12.7936(8)Å c=17.3523(12)Å
α=90.00° β=90.00° γ=90.00°
2(S)-amino-3-(1H-imidazol-4(5)-yl)propyl 4-bromobenzyl ether dihydrochloride
C13H18BrN3O2,2Cl1
Acta Crystallographica Section C (2000) 56, 5 e216-e217
a=7.5530(2)Å b=12.9964(6)Å c=17.7800(9)Å
α=90.00° β=90.00° γ=90.00°
Compound X
C32H21N2O7S2
Journal of the American Chemical Society (2011) 133, 14558-14561
a=12.113(3)Å b=19.347(4)Å c=11.825(3)Å
α=90° β=95.49(3)° γ=90°
Compound X
C32H20N2O6S2
Journal of the American Chemical Society (2011) 133, 14558-14561
a=10.312(2)Å b=31.026(6)Å c=8.4040(17)Å
α=90° β=95.68(3)° γ=90°
C95H115Cl3F12N8O19P2
C95H115Cl3F12N8O19P2
Journal of the American Chemical Society (2012) 134, 1860-1868
a=14.484(3)Å b=32.495(7)Å c=22.293(5)Å
α=90° β=99.43(3)° γ=90°